FM 8-284 - Treatment of Biological Warfare Agent Casualties.pdf

(1558 KB) Pobierz
appa
ARMY FM 8-284
NAVY NAVMED P-5042
AIR FORCE AFMAN (I) 44-156
MARINE CORPS MCRP 4-11.1C
FIELD MANUAL
TREATMENT OF
BIOLOGICAL WARFARE
AGENT CASUALTIES
HEADQUARTERS, DEPARTMENTS OF THE ARMY, THE NAVY, AND
THE AIR FORCE, AND COMMANDANT, MARINE CORPS
DISTRIBUTION RESTRICTION: Approved for public release; distribution is unlimited.
17 July 2000
240805492.003.png
C1, FM 8-284
NTRP 4-02.23 (NAVMED P-5042)
AFMAN (I) 44-156
MCRP 4-11.1C
Change 1
HEADQUARTERS
DEPARTMENTS OF THE ARMY,
THE NAVY, AND THE AIR FORCE,
AND COMMANDANT, MARINE CORPS
Washington, DC 8 July 2002
TREATMENT OF BIOLOGICAL WARFARE AGENT CASUALTIES
1. Change FM 8-284/NAVMED P-5042/AFMAN (I) 44-156/MCRP 4-11.1C, 17 July 2000, as follows:
Remove old pages
Insert new pages
i and ii
i and ii
1-11 and 1-12
1-11 and 1-12
1-17 and 1-18
1-17 and 1-19
2-1 through 2-4
2-1 through 2-4
2-13 and 2-14
2-13 and 2-14
2-21 and 2-22
2-21 and 2-22
Glossary-3 and Glossary-4
Glossary-3 and Glossary-4
Glossary-7
Glossary-7
References-1 and References-2
References-1 and References-2
Index-3 through Index-6
Index-3 through Index-6
Back cover
Back cover
2. New or changed material is indicated by a star ( ).
3. File this transmittal sheet in front of the publication.
DISTRIBUTION RESTRICTION: Approved for public release, distribution is unlimited.
C1, FM 8-284/NTRP 4-02.23 (NAVMED P-5042)/AFMAN (I) 44-156/MCRP 4-11.1C
By Order of the Secretary of the Army:
Official:
ERIC K. SHINSEKI
General, United States Army
JOEL B. HUDSON
Administrative Assistant to the
Secretary of the Army
By Direction of the Chief of Naval Operations:
Official:
R.G. SPRIGG
Rear Admiral, USN
Navy Warfare Development Command
By Order of the Secretary of the Air Force:
Official:
PAUL K. CARLTON, JR.
Lieutenant General, USAF, MC, CFS
Surgeon General
By Direction of the Commandant of the Marine Corps:
Official:
EDWARD HANLON, JR.
Lieutenant General, U.S. Marine Corps
Commanding General
Marine Corps Combat Development Command
DISTRIBUTION:
US Army: Active Army, USAR, and ARNG : To be distributed in accordance with the initial
distribution number 115795, requirements for FM 8-284.
US Air Force: F
US Marine Corps: PCN: 14400008000
Chief of Staff
240805492.004.png 240805492.005.png 240805492.006.png 240805492.001.png
PIN: 077922-000
PCN: 14400008000
C1, FM 8-284
NTRP 4-02.23 (NAVMED P-5042)
AFMAN (I) 44-156
MCRP 4-11.1C
FIELD MANUAL
HEADQUARTERS
NO. 8-284
DEPARTMENTS OF THE ARMY,
NTRP 4-02.23 (NAVMED P-5042)
THE NAVY, AND THE AIR FORCE,
AIR FORCE MANUAL (INTERSERVICE)
AND COMMANDANT, MARINE CORPS
NO. 44-156
Washington, DC 17 July 2000
MARINE CORPS
MCRP 4-11.1C
TREATMENT OF BIOLOGICAL WARFARE AGENT CASUALTIES
TABLE OF CONTENTS
Page
PREFACE
.........................................................................................
vii
CHAPTER 1. INTRODUCTION
1-1. The Threat of Biologic al Warfare Agents Against United States
Forces and Civilian Populations ............................................ 1-1
1-2. Modes of Delivery .................................................................. 1-1
1-3. Employment of Biological Warfare Agents .................................... 1-2
1-4. Classification of Biological Warfare Agents ................................... 1-3
1-5. Portals of Entry ..................................................................... 1-3
1-6. Environmental Detection .......................................................... 1-4
1-7. Diagnosis ............................................................................. 1-5
1-8. Specimen Collection ................................................................ 1-6
1-9. Specimen Labeling .................................................................. 1-9
1-10. Specimen Handling and Shipment ............................................... 1-10
1-11. Chain of Custody Responsibilities ............................................... 1-10
1-12. Identification Methods for Biological Warfare Agents ....................... 1-11
1-13. Therapy ............................................................................... 1-12
1-14. Case Reporting and Epidemiological Assessment ............................. 1-12
1-15. Prevention ............................................................................ 1-12
1-16. Protective Equipment............................................................... 1-13
1-17. First Aid .............................................................................. 1-14
1-18. Protective Measures and Handling of Casualties .............................. 1-14
1-19. Patient Decontamination ........................................................... 1-15
1-20. Infection Control .................................................................... 1-16
1-21. Medical Evacuation ................................................................. 1-16
1-22. Aeromedical Isolation Team ...................................................... 1-18
1-23. Investigational New Drugs and Off-Label Indications ........................ 1-18
CHAPTER
I. Introduction ......................................................................... 2-1
2-1. General ................................................................................. 2-1
2. BACTERIAL AGENTS
Distribution Restriction: Approved for public release; distribution is unlimited.
i
Section
240805492.002.png
Zgłoś jeśli naruszono regulamin